NASEM publishes guidance for campus climate surveys measuring sexual harassment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Action Collaborative on Preventing Sexual Harassment in Higher Education—part of the National Academies of Science, Engineering, and Medicine—published its first collaborative resource: a Guidance Document on Measuring Sexual Harassment Prevalence Using Campus Climate Surveys.  

The goal of the resource is to help the higher education ecosystem conduct climate surveys that align with best practices identified by research.

Authored by the Action Collaborative’s Evaluation Working Group, this guide provides key considerations for collecting population-based data in the form of a large-scale survey such as a campus climate survey, with the goal of measuring the prevalence of sexual harassment.

The guidance document can be found here

On Oct. 12-13, the Action Collaborative will host its third annual public summit, an open forum for those in the higher education ecosystem to identify, discuss, and elevate approaches to addressing and preventing sexual harassment. 

Table of Contents

YOU MAY BE INTERESTED IN

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States.  Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

In the evolving landscape of pediatric oncology, survivorship research has become an essential component of our mission to improve long-term patient outcomes. At City of Hope, we are focused on not only curing childhood cancers but also ensuring that survivors live the healthiest lives possible. A significant part of my research has been dedicated to mitigating the long-term toxicities of cancer therapy—particularly cardiovascular complications that can arise decades after treatment.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login